Acyclovir (as sodium) 500mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains sodium 49mg/vial. Give by IV infusion over 1 hour. Mucocutaneous herpes simplex ...

May give with food. Genital herpes: Initially 200mg every 4hrs (5 times daily) for 10 days. Chronic: 400mg 2 times daily or 200mg 3–5 times daily for up to 12 months, then reevaluate ...

Aciclovir or acyclovir is an antiviral agent used to treat cold sores around the mouth caused by the herpes simplex virus, chickenpox, and shingles. Rashes of the skin are usually not threatening ...

First clinical episode of genital herpes: Acyclovir 200mg PO 5 times a day for 7-10 days or until clinical resolution is attained. First clinical episode of herpes proctitis: Acyclovir 400mg PO 5 ...

Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...

"This would be a wonderful development, as antiviral drugs like acyclovir have only proven to be partially effective in ...

The approach proved successful with the synthesis of acycloguanosine, also known as acyclovir (Zovirax). This work proved that drugs can be selective. On this principle, her colleagues later developed ...

Candel Therapeutics, Inc. (NASDAQ:CADL) was able to report positive interim results from its phase 2 randomized study using ...

Thirty years ago, just three drugs were available for the treatment of viral infections, but now more than forty have been approved. What have been the guiding principles in these achievements and ...

Thus logically a combination of high dose steroids to reduce the inflammation together with an antiviral drug such as ...

Find all the commercial and brand names of generic drug called Acyclovir. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Health Canada approves new indication for Merck’s Prevymis for prevention of CMV disease in high-risk adult kidney transplant recipients: Kirkland, Quebec Monday, April 22, 2024 ...